Groowe Groowe / Newsroom / ABBV
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ABBV News

ABBVIE INC.

Advanced Endometrial Cancer Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the Future of Advanced Endometrial Cancer Therapeutics Space | DelveInsight

globenewswire.com
MRK AZN IOBT ABBV

2026 Back of the Eye Disorders Market Research Report (2nd Edition): A Development Pipeline Consisting of ~690 Approved or Clinical-Stage Therapeutic Candidates

globenewswire.com
KODK OTLK ALDX OCUL REGN ABBV NVS BHC SUN

AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma

prnewswire.com
ABBV

Form 8-K

sec.gov
ABBV

AbbVie Completes Acquisition of Apogee Therapeutics

prnewswire.com
ABBV APGE

Direct Relief Medical Aid to U.S. Safety Net Tops $3 Billion

accessnewswire.com
TEVA LLY ABBV ALC JNJ SNY PFE FDX ABT

Autoimmune Uveitis Market to Expand at a CAGR of 7% During the Forecast Period (2026-2036) as Novel Treatments Challenge the Existing Therapeutic Landscape | DelveInsight

prnewswire.com
ABBV AMGN BMY NVS PFE UNH

Allergan Aesthetics Unveils the Layered Beauty Report, Advancing the Global Conversation Around Aesthetic Care

prnewswire.com
ABBV

A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture

prnewswire.com
INMD EOLS ABBV CNXU ESTA

SkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings

prnewswire.com
ABBV